Designing population pharmacokinetic studies: Performance of mixed designs

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 25, Issue 3-4, 2000, Pages 231-239

  Fadiran, E O ^a   Jones, C D ^b   Ette, E I ^c  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Solvay Pharmaceuticals Inc   (United States)

^c Ventex Pharmacokinetics   (United States)

Author keywords

Population pharmacokinetics

Indexed keywords

DRUG;

ACCURACY; ARTICLE; BOLUS INJECTION; COMPARTMENT MODEL; COMPUTER SIMULATION; DRUG COST; DRUG DESIGN;

HUMANS; PHARMACOKINETICS; SAMPLE SIZE;

EID: 0034438883     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03192320     Document Type: Article

References (18)

1. Designs for population pharmacodynamics: Value of pharmacokinetic data and population analysis
2. Experimental design and efficient parameter estimation in population pharmacokinetics
3. Design of population pharmacokinetic studies
4. Designing cross-sectional pharmacokinetic studies: Implications for pediatric and animal studies
5. Comparison of some practical sampling strategies for population pharmacokinetic studies
6. On error in the recording of sampling times and parameter estimation from repeated measures pharmacokinetic data
7. Clinical simulation: Streamlining your drug development process
8. Balanced designs in longitudinal population pharmacokinetic studies
9. Ignorability and parameter estimation in longitudinal pharmacokinetic studies
10. Statistical graphics in pharmacokinetics and pharmacodynamics: A tutorial
11. Do we need full compliance data for population pharmacokinetic analysis
12. Interpretation of simulation studies for efficient estimation of population pharmacokinetic parameters
13. Analysis of animal pharmacokinetic data: Performance of the one point per animal design
14. The importance of modeling interoccasion variability in population pharmacokinetic analyses